Source: NASDAQ Stocks / 13 Nov 2024 02:27:11 America/New_York
Fintel reports that on November 12, 2024, Leerink Partners upgraded their outlook for Bristol-Myers Squibb (LSE:0R1F) from Market Perform to Outperform.
https://www.nasdaq.com/articles/leerink-partners-upgrades-bristol-myers-squibb-lse-0r1f